Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Two-part Multicenter Study: a Randomized, Double-blind, Placebo-controlled Dose-escalation Safety Phase (Part 1) Followed by Double-blind, Placebo-controlled, Adaptive Phase (Part 2) Study to Evaluate the Safety and Efficacy of AB-1003 in Adult Subjects With LGMD2I/R9 Mutations in the Gene Encoding Fukutin Related Protein (FKRP)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05230459
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:23.299293+00:00
Published At
2026-02-20T00:00:00+00:00
Record Updated At
2026-02-20
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Limb Girdle Muscular Dystrophy", "Limb-Girdle Muscular Dystrophy Type 2", "LGMD2I", "Muscular Dystrophy", "LGMD2", "LGMD", "FKRP", "FKRP Mutation", "Fukutin Related Protein"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-02-20"
protocolSection.identificationModule.nctId
"NCT05230459"
protocolSection.identificationModule.officialTitle
"A Two-part Multicenter Study: a Randomized, Double-blind, Placebo-controlled Dose-escalation Safety Phase (Part 1) Followed by Double-blind, Placebo-controlled, Adaptive Phase (Part 2) Study to Evaluate the Safety and Efficacy of AB-1003 in Adult Subjects With LGMD2I/R9 Mutations in the Gene Encoding Fukutin Related Protein (FKRP)"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Limb Girdle Muscular Dystrophy (protocolSection.conditionsModule.conditions)
  • Limb-Girdle Muscular Dystrophy Type 2 (protocolSection.conditionsModule.conditions)
  • LGMD2I (protocolSection.conditionsModule.conditions)
  • Muscular Dystrophy (protocolSection.conditionsModule.conditions)
  • LGMD2 (protocolSection.conditionsModule.conditions)
  • LGMD (protocolSection.conditionsModule.conditions)
  • FKRP (protocolSection.conditionsModule.conditions)
  • FKRP Mutation (protocolSection.conditionsModule.conditions)
  • Fukutin Related Protein (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.